New Anti-Vegf Drugs In Ophthalmology.

New Anti-Vegf Drugs In Ophthalmology. Curr Drug Targets. 2020 Apr 27;: Authors: Campa C Abstract This review focuses on 5 new anti-VEGF drugs in advanced stage of clinical development (i.e. phase 3): conbercept, brolucizumab, port delivery system with ranibizumab, abicipar pegol and faricimab. Results of clinical trials and advantages of each drug compared to the available molecules are discussed in detail. PMID: 32342814 [PubMed - as supplied by publisher]
Source: Current Drug Targets - Category: Drugs & Pharmacology Authors: Tags: Curr Drug Targets Source Type: research